INSULCLOCK addresses the opportunity of providing a new product Within the growing market for diabetes care, a very serious and painful disease with an expected global patient pool of 380 million by 2025.More specifically, INSULCLOCK approaches the insulin pens market which totaled above 8 billion € in 2013, with a 9% CAGR for the next years.More than 25% of diabetics depend on insulin injections ...